全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2018 

经尿道1470nm激光三叶法前列腺剜除术与等离子双极前列腺电切术的临床疗效比较 Comparison of Clinical Effect Between Transurethral 1 470 nm Diode Laser Enucleation of the Prostate and Transurethral Bipolar Plasmakinetic Resection of Prostate

Keywords: 前列腺增生,1 470nm半导体激光,半导体激光前列腺剜除术,等离子双极前列腺切除术

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:比较1 470nm半导体激光三叶法前列腺剜除术(DiLEP)与经尿道等离子双极前列腺电切术(PKRP)的临床疗效。方法:分析2016年2月至2017年4月武汉大学人民医院收治的良性前列腺增生症(BPH)而导致膀胱出口梗阻的患者162例,数字法随机分成2组:DiLEP组(80例)和PKRP组(82例)。术后随访3个月,比较两组围手术期相关指标。结果:PKRP组术前国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)、残余尿量(PVR)分别为(25.7±5.2)分、(4.9±0.9)分、(7.6±1.6)ml/s、(85.9±90.0)ml,术后各项指标分别为(5.6±1.6)分、(2.0±1.1)分、(18.0±1.1)ml/s、(8.6±4.5)ml;DiLEP组术前IPSS、QOL、Qmax、PVR分别为(24.6±6.9)分、(5.1±0.8)分、(7.8±1.5)ml/s、(109.1±110.5)ml,术后各项指标分别为(5.4±1.6)分、(2.1±1.0)分、(18.1±1.9)ml/s、(8.7±4.8)ml,两组术后IPSS、QOL、Qmax、PVR均比术前改善(P<0.05),但组间比较差异无统计学意义(P>0.05)。DiLEP组在术中出血量及血红蛋白下降,术后膀胱冲洗时间、置管时间和术后住院时间,均较PKRP组短(P<0.05)。此外,DiLEP组在手术时间较PKRP短(P<0.05),所切除前列腺重量较PKRP组重。结论:两种切除方式在近期疗效无明显差异,但DiLEP术中出血量少,尿管留置时间短,安全性较高

References

[1]  Woo MJ,Ha YS,Lee JN,et al.Comparison of surgical outcomes between holmium laser enucleation and transurethral resection of the prostate in patients with detrusor underactivity[J],Int Neurourol J,2017,21(1):46-52.
[2]  Fligou F,Kallidonis P,Flaris N,et al.Deep sedation in green light laser prostatectomy[J].Urol Ann,2016,8(2):203-207.
[3]  Guo HQ,Zhou GB,Liu HM,et al.Prostatic hyperplasia treatment by transurethral enucleation of the prostate using a 2-μm laser[J].Indian J Surg,2015,77(Suppl 3):1 073-1 076.
[4]  Liu Z,Li YW,Wu WR,et al.Long-term clinical efficacy and safety profile of transurethral resection of prostate versus plasmakinetic resection of the prostate for benign prostatic hyperplasia[J].Urology,2017,103:198-203.
[5]  Van AB,Barkin J,Elterman DS.Medical therapy for benign prostatic hyperplasia:a review[J].Can J Urol,2015,22(Suppl 1):7-17.
[6]  Torz C,Poletajew S,Radziszewski P.A prospective,randomized trial comparing the use of KTP(green light)laser versus electroresection-supplement laser in the treatment of benign prostatic hyperplasia[J].Cent European J,2016,69(4):391-395.
[7]  Beltrami P,Guttilla A,Fumo G,et al.Treating cervico-urethral obstructions with laser diode:initial clinical experience[J].Urologia,2012,79(Suppl 19):58-66.
[8]  Tammela T.Benign prostatic hyperplasia.Practical treatment guidelines[J].Drugs Aging,1997,10(5):349-366.
[9]  Gravas S,Bachmann A,Reich O,et al.Critical review of lasers in benign prostatic hyperplasia(BPH)[J].BJU Int,2011,107(7):1 030-1 043.
[10]  陈忠,叶章群,吴嘉,等.1 470nm半导体激光汽化术治疗良性前列腺增生的疗效及安全性研究[J].中华泌尿外科杂志,2015,36(3):135-138.Chen Z,Ye ZQ,Wu J,et al.Safety and effectiveness of 1 470nm diode laser vaporization for the treatment of benign prostatic hyperplasia[J].Chinese Journal of Urology,2015,36(3):135-138.
[11]  Seitz M,Sroka R,Gratzke C,et al.The diode laser:a novelside-firing approach for laser vaporization of the human prostate:immediate efficacy and 1-year followup[J].Eur Urol,2007,52(6):1 717-1 722.
[12]  Zhao Y,Liu C,Zhou G,et al.A retrospective evaluation of benign prostatic hyperplasia treatment by transurethral vaporization using a 1 470nm laser[J].Photomed Laser Surg,2013,31(12):626-629.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133